{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:51:05Z","timestamp":1770691865510,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10157-025-02791-9","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:11:24Z","timestamp":1763986284000},"page":"298-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationships of Janus kinase 2 with chronic kidney diseases: a two-sample Mendelian randomisation study"],"prefix":"10.1007","volume":"30","author":[{"given":"Yanjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tana","family":"Wuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2791_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"KDIGO","year":"2021","unstructured":"KDIGO. Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:S1-87. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003.","journal-title":"Kidney Int"},{"key":"2791_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100438","volume":"20","author":"J Sundstrom","year":"2022","unstructured":"Sundstrom J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries: the CaReMe CKD study. Lancet Regional Health - Europe. 2022;20:100438. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100438.","journal-title":"Lancet Regional Health - Europe"},{"key":"2791_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","journal-title":"Lancet"},{"key":"2791_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786\u2013802. https:\/\/doi.org\/10.1016\/S0140-6736(21)00519-5.","journal-title":"Lancet"},{"key":"2791_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"JAMA"},{"key":"2791_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O\u2019Shea JJ. Mechanisms and consequences of jak-stat signaling in the immune system. Nat Immunol. 2017;18:374\u201384. https:\/\/doi.org\/10.1038\/ni.3691.","journal-title":"Nat Immunol"},{"key":"2791_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the jak-stat signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8:204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7.","journal-title":"Signal Transduct Target Ther"},{"key":"2791_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2791_CR9","doi-asserted-by":"publisher","first-page":"1233259","DOI":"10.3389\/fcell.2023.1233259","volume":"11","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang W, Zhang J, Gao S, Xu T, Yin Y. Jak\/stat signaling in diabetic kidney disease. Front Cell Dev Biol. 2023;11:1233259. https:\/\/doi.org\/10.3389\/fcell.2023.1233259.","journal-title":"Front Cell Dev Biol"},{"key":"2791_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MNH.0000000000000079","volume":"24","author":"FR Brosius","year":"2015","unstructured":"Brosius FR, He JC. Jak inhibition and progressive kidney disease. Curr Opin Nephrol Hypertens. 2015;24:88\u201395. https:\/\/doi.org\/10.1097\/MNH.0000000000000079.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2791_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1681\/ASN.2010030286","volume":"21","author":"FR Brosius","year":"2010","unstructured":"Brosius FR, Banes-Berceli A. A new pair of socs for diabetic nephropathy. J Am Soc Nephrol. 2010;21:723\u20134. https:\/\/doi.org\/10.1681\/ASN.2010030286.","journal-title":"J Am Soc Nephrol"},{"key":"2791_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ki.2010.158","volume":"78","author":"PY Chuang","year":"2010","unstructured":"Chuang PY, He JC. Jak\/stat signaling in renal diseases. Kidney Int. 2010;78:231\u20134. https:\/\/doi.org\/10.1038\/ki.2010.158.","journal-title":"Kidney Int"},{"key":"2791_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2337\/db08-1328","volume":"58","author":"CC Berthier","year":"2009","unstructured":"Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, et al. Enhanced expression of janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes. 2009;58:469\u201377. https:\/\/doi.org\/10.2337\/db08-1328.","journal-title":"Diabetes"},{"key":"2791_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2215\/CJN.11010919","volume":"15","author":"J Tao","year":"2020","unstructured":"Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, et al. Jak-stat activity in peripheral blood cells and kidney tissue in iga nephropathy. Clin J Am Soc Nephrol. 2020;15:973\u201382. https:\/\/doi.org\/10.2215\/CJN.11010919.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2791_CR15","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1038\/s41598-019-41106-3","volume":"9","author":"F Patera","year":"2019","unstructured":"Patera F, Cudzich-Madry A, Huang Z, Fragiadaki M. Renal expression of jak2 is high in polycystic kidney disease and its inhibition reduces cystogenesis. Sci Rep. 2019;9:4491. https:\/\/doi.org\/10.1038\/s41598-019-41106-3.","journal-title":"Sci Rep"},{"key":"2791_CR16","doi-asserted-by":"publisher","first-page":"F479","DOI":"10.1152\/ajprenal.00329.2017","volume":"315","author":"Y Jing","year":"2018","unstructured":"Jing Y, Wu M, Zhang D, Chen D, Yang M, Mei S, et al. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the jak2-stat3 pathway. Am J Physiol Renal Physiol. 2018;315:F479\u201386. https:\/\/doi.org\/10.1152\/ajprenal.00329.2017.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2791_CR17","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"SG Davey","year":"2014","unstructured":"Davey SG, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98. https:\/\/doi.org\/10.1093\/hmg\/ddu328.","journal-title":"Hum Mol Genet"},{"key":"2791_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601. https:\/\/doi.org\/10.1136\/bmj.k601.","journal-title":"BMJ"},{"key":"2791_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12610-023-00192-0","volume":"33","author":"YJ Xi","year":"2023","unstructured":"Xi YJ, Wen R, Zhang R, Dong QR, Zhang HY, Su QY, et al. Causal association between jak2 and erectile dysfunction: a mendelian randomization study. Basic Clin Androl. 2023;33:18. https:\/\/doi.org\/10.1186\/s12610-023-00192-0.","journal-title":"Basic Clin Androl"},{"issue":"1","key":"2791_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2023.2257300","volume":"26","author":"Y Xi","year":"2023","unstructured":"Xi Y, Wen R, Zhang R, Dong Q, Hou S, Zhang S. Genetic evidence supporting a causal role of janus kinase 2 in prostate cancer: a mendelian randomization study. Aging Male. 2023;26(1):2257300. https:\/\/doi.org\/10.1080\/13685538.2023.2257300.","journal-title":"Aging Male"},{"key":"2791_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12672-024-01269-6","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Shen G, Yang P, Wu M, Li J, Li Z, et al. Causality between autoimmune diseases and breast cancer: a two-sample mendelian randomization study in a European population. Discov Oncol. 2024;15:396. https:\/\/doi.org\/10.1007\/s12672-024-01269-6.","journal-title":"Discov Oncol"},{"key":"2791_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"key":"2791_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden J, Del GMF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et al. Improving the accuracy of two-sample summary-data mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48:728\u201342. https:\/\/doi.org\/10.1093\/ije\/dyy258.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2791_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103276","volume":"22","author":"M Benucci","year":"2023","unstructured":"Benucci M, Bernardini P, Coccia C, De Luca R, Levani J, Economou A, et al. Jak inhibitors and autoimmune rheumatic diseases. Autoimmun Rev. 2023;22(4):103276. https:\/\/doi.org\/10.1016\/j.autrev.2023.103276.","journal-title":"Autoimmun Rev"},{"key":"2791_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102041","volume":"34","author":"I Prieto","year":"2023","unstructured":"Prieto I, Kavanagh M, Jimenez-Castilla L, Pardines M, Lazaro I, Herrero DRI, et al. A mutual regulatory loop between mir-155 and socs1 influences renal inflammation and diabetic kidney disease. Mol Ther Nucleic Acids. 2023;34:102041. https:\/\/doi.org\/10.1016\/j.omtn.2023.102041.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2791_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","volume":"7","author":"P Ronco","year":"2021","unstructured":"Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, et al. Membranous nephropathy Nat Rev Dis Primers. 2021;7:69. https:\/\/doi.org\/10.1038\/s41572-021-00303-z.","journal-title":"Membranous nephropathy Nat Rev Dis Primers"},{"key":"2791_CR27","doi-asserted-by":"publisher","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","volume":"11","author":"Q Hu","year":"2023","unstructured":"Hu Q, Bian Q, Rong D, Wang L, Song J, Huang HS, et al. JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 2023;11:1110765. https:\/\/doi.org\/10.3389\/fbioe.2023.1110765.","journal-title":"Front Bioeng Biotechnol"},{"key":"2791_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845767","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Liu J, Lin B, Zhang Y, Ma M, Yang M, et al. Novel biomarkers in membranous nephropathy. Front Immunol. 2022;13:845767. https:\/\/doi.org\/10.3389\/fimmu.2022.845767.","journal-title":"Front Immunol"},{"key":"2791_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.kint.2022.09.008","volume":"103","author":"NM Tomas","year":"2023","unstructured":"Tomas NM, Dehde S, Meyer-Schwesinger C, Huang M, Hermans-Borgmeyer I, Maybaum J, et al. Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice. Kidney Int. 2023;103:297\u2013303. https:\/\/doi.org\/10.1016\/j.kint.2022.09.008.","journal-title":"Kidney Int"},{"issue":"20","key":"2791_CR30","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1158\/0008-5472.CAN-13-0318","volume":"73","author":"D Vindrieux","year":"2013","unstructured":"Vindrieux D, Augert A, Girard CA, Gitenay D, Lallet-Daher H, Wiel C, et al. Pla2r1 mediates tumor suppression by activating jak2. Cancer Res. 2013;73(20):6334\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0318.","journal-title":"Cancer Res"},{"key":"2791_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2017.11.002","volume":"56","author":"O Sukocheva","year":"2019","unstructured":"Sukocheva O, Menschikowski M, Hagelgans A, Yarla NS, Siegert G, Reddanna P, et al. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers. Semin Cancer Biol. 2019;56:116\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.002.","journal-title":"Semin Cancer Biol"},{"issue":"18","key":"2791_CR32","doi-asserted-by":"publisher","first-page":"16304","DOI":"10.1074\/jbc.M212321200","volume":"278","author":"X Yu","year":"2003","unstructured":"Yu X, Kennedy RH, Liu SJ. Jak2\/stat3, not erk1\/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem. 2003;278(18):16304\u20139. https:\/\/doi.org\/10.1074\/jbc.M212321200.","journal-title":"J Biol Chem"},{"issue":"2","key":"2791_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","volume":"104","author":"C Guiter","year":"2004","unstructured":"Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P, et al. Constitutive stat6 activation in primary mediastinal large B-cell lymphoma. Blood. 2004;104(2):543\u20139. https:\/\/doi.org\/10.1182\/blood-2003-10-3545.","journal-title":"Blood"},{"key":"2791_CR34","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","volume":"55","author":"K Kiryluk","year":"2023","unstructured":"Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, et al. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet. 2023;55:1091\u2013105. https:\/\/doi.org\/10.1038\/s41588-023-01422-x.","journal-title":"Nat Genet"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02791-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02791-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02791-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:29:10Z","timestamp":1770629350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02791-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2791"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02791-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This MR study is performed using GWAS summary statistics, and ethical approval was obtained by each GWAS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}